BCTQ scores and a set of physiological (i.e., motor and sensory conduction studies, static two-point discrimination, and pressure sensitivity) and clinical (i.e., hand dexterity) outcome measures were assessed at baseline and at 3, 6, and 12 months after the surgery
It's a catastrophic variable that can invalidate months or even years of work
PI3K/Akt Survival Pathway Parallel to cAMP signaling, GLP-1 receptor activation stimulates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway, a critical mediator of cell survival and metabolic regulation
MT-2 stimulates melanogenesis in melanocytes, producing a tan that develops gradually over 714 days of repeated dosing
If other measures prove ineffective, switching to a different GLP-1 medication or discontinuing them altogether may be the best solution